Individuals Coming Off Anti-Obesity Jabs Regain Weight Far More Rapidly Than People Using Diet and Exercise

A recent study reveals that individuals who discontinue blockbuster slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Research printed in a leading medical journal points out that while overweight individuals can lose a large proportion of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"Users buying these treatments should be cognizant of the potential of quick rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of regain suggests a reversion to pre-treatment weight in about a year and a half.

Comparing Approaches

The research, which examined dozens of trials involving thousands of patients, compared the results of these new drugs with other pills.

Scientists note that individuals who lose weight through diet and exercise generally see a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Regain

Experts suggest the mode of action of the drugs is key to understanding the heightened weight return.

GLP-1 drugs copy a natural hormone called GLP-1, which controls appetite.

"Long-term administration of the hormone levels far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Condition?

The NHS advise the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

Many experts contend that, due to the high risk of weight regain, the treatment is often life-long.

This perspective is supported by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.

User Testimonies

Users who have stopped the medication describe a sudden return of cravings.

"I experienced a trigger activating and you're instantly starving," recalled one woman.

The struggle is exacerbated if patients have not adopted sustainable lifestyle or habit changes during treatment.

Significant Use

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among females than men.
• The middle-aged age group shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, clinicians emphasize that while these medications are powerful tools for weight loss, they are not a permanent fix and lasting health benefits relies on combined lifestyle changes.